Mostrar el registro sencillo del ítem

dc.contributor.author
Rodriguez-Tudela, Juan Luis  
dc.contributor.author
Gomez-Lopez, Alicia  
dc.contributor.author
Arendrup, Maiken C.  
dc.contributor.author
Garcia, Guillermo Manuel  
dc.contributor.author
Perlin, David S.  
dc.contributor.author
Lass-Flörl, Cornelia  
dc.contributor.author
Cuenca-Estrella, Manuel  
dc.date.available
2020-02-14T20:51:08Z  
dc.date.issued
2010-07  
dc.identifier.citation
Rodriguez-Tudela, Juan Luis; Gomez-Lopez, Alicia; Arendrup, Maiken C.; Garcia, Guillermo Manuel; Perlin, David S.; et al.; Comparison of caspofungin MICs by means of EUCAST method EDef 7.1 using two different concentrations of glucose; American Society for Microbiology; Antimicrobial Agents and Chemotherapy; 54; 7; 7-2010; 3056-3057  
dc.identifier.issn
0066-4804  
dc.identifier.uri
http://hdl.handle.net/11336/97694  
dc.description.abstract
According to the product insert for Cancidas (caspofungin acetate), the drug must not be diluted in solutions containing glucose as this decreases caspofungin stability. The aim of this study was to compare caspofungin MICs for a collection of yeasts by means of EUCAST method EDef7.1 but using two different concentrations of glucose: 2% versus 0.2%. MICs were identical or within one 2-fold dilution for 93 out of 95 strains (97.9%), showing that glucose does not interfere with susceptibility.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
American Society for Microbiology  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Echinocandinas  
dc.subject
Resistencia  
dc.subject
Evaluación sensibilidad  
dc.subject
Caspofungina  
dc.subject.classification
Enfermedades Infecciosas  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Comparison of caspofungin MICs by means of EUCAST method EDef 7.1 using two different concentrations of glucose  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2020-02-13T19:00:09Z  
dc.journal.volume
54  
dc.journal.number
7  
dc.journal.pagination
3056-3057  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Washington  
dc.description.fil
Fil: Rodriguez-Tudela, Juan Luis. Centro Nacional de Microbiología; España  
dc.description.fil
Fil: Gomez-Lopez, Alicia. Centro Nacional de Microbiología; España  
dc.description.fil
Fil: Arendrup, Maiken C.. Statens Serum Institut;  
dc.description.fil
Fil: Garcia, Guillermo Manuel. Universidad Nacional del Litoral; Argentina  
dc.description.fil
Fil: Perlin, David S.. Public Health Research Institute; Estados Unidos  
dc.description.fil
Fil: Lass-Flörl, Cornelia. Medizinische Universitat Innsbruck; Austria  
dc.description.fil
Fil: Cuenca-Estrella, Manuel. Centro Nacional de Microbiología; España  
dc.journal.title
Antimicrobial Agents and Chemotherapy  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1128/AAC.00597-10